Skip to content

Pro-Dex, Inc. (PDEX) Company Overview

Company Analysis

Pro-Dex, Inc. PDEX

A comprehensive view of key metrics, scores, and financial health for Pro-Dex, Inc.

Overview of Pro-Dex, Inc.

PDEX NCM
Healthcare Medical Instruments & Supplies Framework: Medical Devices & Diagnostics Micro Cap
Pro-Dex, Inc. (PDEX), is a Micro Cap company, in the Medical Instruments & Supplies industry, last closed at $60.66, about 28.5% overvalued vs fair value, +111.3% 1Y return, placing in the top 25% of its sector.
Metrics P/E 14.2× Rev Growth 16.5% ROE 32.4% Gross Margin 31.4%
USD 60.66
-2.51%
(Delayed)
• Vol 90d: 60.7%
52-Week Range
Market Cap
$194.31M
Enterprise Value
$203.59M
Overall Score
Overall
Growth
Good
Profitability
Good
Health
Fair
Efficiency
Fair
Valuation
Fair
Growth
Good
Profitability
Good
Health
Fair
Efficiency
Fair
Valuation
Fair
Completeness: 88%
Confidence: 91%
Updated: Oct 24
Top Beats

Quick Facts

HQ Irvine, CA
Employees 179
Fiscal year Jun 30

Next Events

Earnings Oct 29 Estimated

Fair Value Snapshot

Bear Base Bull
$39
$43
$48
Current: $60.66 -29% vs base

Engine Room Money Flow™

Micro Cap

Medical Devices & Diagnostics - Where revenue goes and how value is created

Flow Steps
Total Revenue
$77.5M
16.5%%
Gross Profit
$24.3M
24.7%%
Operating Income (GAAP)
$13.0M
21.5%%
EBITDA
$20.2M
43.1%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Medical Devices & Diagnostics

Quality & Reliability Indicators

Gross Margin
31.4%
Poor

Gross Profit / Revenue — primary moat signal for MedTech. ≥65% indicates IP-protected consumables with strong pricing power.

Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium

Where It Leaks

Cash Flow Health some concerns
Moderate efficiency issues detected. Review active leaks below for improvement areas.
1
Active Leaks
0/1
Improving
1
High Impact
0
Critical
Moat Analysis Medical Devices & Diagnostics

Competitive Advantage Assessment

Evaluating Pro-Dex, Inc.'s durable competitive advantages across 6 defense dimensions

Overall Moat Strength
65
/100
Moderate
Scores based on quantitative metrics and qualitative factors

Key strengths

  • Superior Capital Returns Capital return quality is top-tier (score 0.96). High ROIC indicates the business is reinvesting at attractive rates.
  • Strong Operating Margin vs Peers Operating margin level is strong vs peers (score 0.84). SG&A discipline is converting gross margin into operating profit efficiently.

Key risks

  • Below-Peer Gross Margins Gross margin quality lags peers (score 0.24). May indicate commodity-like product mix or distributor margin drag.
  • Declining FCF Margin FCF trend score is negative (score 0.31). Declining FCF margin warrants scrutiny of capital allocation discipline.

The dashed ring is the peer median. Defense scores are percentile ranks against peers, so 50 is roughly the typical company in this group.

Upgrade to unlock the signals and evidence behind each defense.

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power & Consumable Moat

Developing
43

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Healthcare: MedTech (Devices & Supplies) vs Industry Peers 100% Coverage
Trade-Off Triangle Visualization A ternary plot showing PDEX's balance between Growth (34.2%), Profitability (33.4%), and Safety (32.4%). Growth 34% Safety 32% Profitability 33%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

71th percentile vs peers
71
Key Signals
Rev Growth YoY 16.4% 71p Revenue CAGR 3Y 18.9% 72p EPS Growth YoY 54.2% 66p EPS CAGR 3Y 28.4% 72p TSR 19.9% 70p
  • ROIC in top 20% of peers (15.2%, 92th percentile)
  • Operating Margin in top 20% of peers (16.8%, 86th percentile)
  • Interest Coverage (EBITDA) in top 20% of peers (24.90, 90th percentile)
  • Cash Flow to Debt Ratio in top 20% of peers (2.00, 88th percentile)
  • Superior capital returns - 2 return metrics above peer median

No significant risks identified for this axis.

Profitability

69th percentile vs peers
70
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

67th percentile vs peers
67
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for Pro-Dex, Inc..

Loading scenario defaults...
Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
$43.36
- - -
-28.5% vs current
Snapshot base estimate
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info
Send Feedback
Please select a category.
0/1000